Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 6/20 | 0.40 |
| ▸ | LIPE | Q05469 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | UGCG | Q16739 | 6/20 | 0.34 |
| ▸ | HTR1D | P28221 | 2/20 | 0.33 |
| ▸ | HTR1B | P28222 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1738778 | 1.00 | ROCK2 (0.40) | ROCK2LIPEKCNH2UGCGHTR1D | |
| SCHEMBL5606335 | 1.00 | ROCK2 (0.40) | ROCK2LIPEKCNH2UGCGHTR1D | |
| SCHEMBL5605999 | 1.00 | ROCK2 (0.40) | ROCK2LIPEKCNH2UGCGHTR1D | |
| SCHEMBL1737879 | 0.94 | FPR2 (0.36) | ROCK2LIPEKCNH2UGCGCHRM2 | |
| SCHEMBL1737717 | 0.88 | ROCK2 (0.41) | ROCK2LIPEUGCG | |
| SCHEMBL1737760 | 0.88 | ROCK2 (0.41) | ROCK2LIPEUGCG | |
| SCHEMBL1737713 | 0.88 | ROCK2 (0.41) | ROCK2LIPEUGCG | |
| SCHEMBL4475863 | 0.86 | CHRM4 (0.40) | ROCK2LIPECHRM2CHRM1CHRM4 | |
| SCHEMBL4475866 | 0.86 | CHRM4 (0.40) | ROCK2LIPECHRM2CHRM1CHRM4 | |
| SCHEMBL4486374 | 0.86 | CHRM4 (0.40) | ROCK2LIPECHRM2CHRM1CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007026219-A2 | COMBINATIONS OF A 5-HT1B ANTAGONIST WITH A NORADRENALIN RE-UPTAKE INHIBITOR OR A SEROTONIN NORADRENALIN REUTAKE INHIBITOR FOR TREATING CNS CONDITIONS | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2007026224-A2 | 5-HT1B ANTAGONIST COMPOSITION FOR DEPRESSION, ANXIETY AND COGNITION | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2007026219-A2 | COMBINATIONS OF A 5-HT1B ANTAGONIST WITH A NORADRENALIN RE-UPTAKE INHIBITOR OR A SEROTONIN NORADRENALIN REUTAKE INHIBITOR FOR TREATING CNS CONDITIONS | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007026224-A2 | 5-HT1B ANTAGONIST COMPOSITION FOR DEPRESSION, ANXIETY AND COGNITION | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | disclosed |